Page last updated: 2024-11-06

3,4-(dichloro)-5-hydroxy-2(5h)-furanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-(dichloro)-5-hydroxy-2(5H)-furanone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91487
CHEMBL ID1173058
SCHEMBL ID1010785
MeSH IDM0184155

Synonyms (34)

Synonym
nsc179787
2(5h)-furanone,4-dichloro-5-hydroxy-
766-40-5
nsc-179787
CHEMBL1173058
STK802150
3,4-dichloro-5-hydroxyfuran-2(5h)-one
3,4-dichloro-2-hydroxy-2h-furan-5-one
AKOS000121238
3,4-dichloro-5-hydroxy-2(5h)-furanone
3,4-dichloro-5-hydroxy-5h-furan-2-one
LU34940000
niosh/lu3494000
2(5h)-furanone, 3,4-dichloro-5-hydroxy-
BBL011015
ccris 3407
einecs 212-166-3
nsc 179787
3,4-(dichloro)-5-hydroxy-2(5h)-furanone
AM804336
SCHEMBL1010785
mucochlorsaure
FT-0698947
mfcd00272415
mucochloric acid lactone
DTXSID20273936
BCP15691
CS-0037410
AS-31848
EN300-21576
A922870
SB61342
2(5h)-furanone, 3,4-dichloro-5-hydroxy-; crotonic acid, 2,3-dichloro-4,4-dihydroxy-, ?-lactone (7ci,8ci); 3,4-dichloro-5-hydroxy-2(5h)-furanone; 5-hydroxy-3,4-dichloro-2-(5h)-furanone; mucochloric acid lactone; nsc 179787
AKOS016843438
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (37)

Assay IDTitleYearJournalArticle
AID1394938Cell cycle arrest in human A549 cells assessed as accumulation at G2/M-phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 6.3 to 7.2%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394933Cell cycle arrest in human A549 cells assessed as accumulation at G1-phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 59.4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394925Cytotoxicity against human LoVo cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394935Cell cycle arrest in human A549 cells assessed as accumulation at G2/M-phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 6.5%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394930Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394953Effect on Pro-caspase-3 protein expression in human A549 cells at 20 uM after 72 hrs by densitometric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394932Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394923Cytotoxicity against p53-/- human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394947Induction of apoptosis in human A549 cells assessed as necrotic cells at 20 uM after 72 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 0.6%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394936Cell cycle arrest in human A549 cells assessed as accumulation at G1-phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 75.2 to 76%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394926Cytotoxicity against human Hep3B cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394922Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394919Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394945Induction of apoptosis in human A549 cells assessed as early apoptotic cells at 20 uM after 72 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 0.4%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394937Cell cycle arrest in human A549 cells assessed as accumulation at S-phase at 10 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 16.8 to 18.5%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394946Induction of apoptosis in human A549 cells assessed as late apoptotic cells at 20 uM after 72 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 0.5%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394955Induction of apoptosis in human A549 cells assessed as caspase-3 cleavage at 20 uM after 72 hrs by Western blot analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394957Anticlonogenic activity against human A549 cells at 10 uM after 24 to 72 hrs by crystal violet staining based microscopic method2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394934Cell cycle arrest in human A549 cells assessed as accumulation at S-phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 34.1%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID492425Antimalarial activity against Plasmodium falciparum2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID1394924Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394952Effect on Bcl-x protein expression in human A549 cells at 20 uM after 72 hrs by densitometric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394929Cytotoxicity against human SJSA1 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394927Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394931Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394921Selectivity index, ratio of IC50 for human BEAS2B cells to IC50 for human A549 cells2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394939Upregulation of Cyclin-B1 protein expression in human A549 cells at 10 uM after 72 hrs by Western blot analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394941Cell cycle arrest in human A549 cells assessed as accumulation at G1-phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 61.5%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394949Effect on Bad protein expression in human A549 cells at 20 uM after 72 hrs by densitometric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394942Cell cycle arrest in human A549 cells assessed as accumulation at S-phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 31.9%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394944Induction of apoptosis in human A549 cells assessed as live cells at 20 uM after 72 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 98.5%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394950Effect on Bax protein expression in human A549 cells at 20 uM after 72 hrs by densitometric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394920Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394928Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394951Effect on Bcl2 protein expression in human A549 cells at 20 uM after 72 hrs by densitometric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394954Effect on cleaved caspase-3 protein expression in human A549 cells at 20 uM after 72 hrs by densitometric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
AID1394943Cell cycle arrest in human A549 cells assessed as accumulation at G2/M-phase at 20 uM after 72 hrs by propidium iodide staining based flow cytometry (Rvb = 6.7%)2018European journal of medicinal chemistry, Apr-25, Volume: 150Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (38.46)18.2507
2000's5 (38.46)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]